Epigenetic profiling is a powerful new method of molecular analysis, that improves the classification of tumors.
Perfect for classifying and analyzing benign and malignant sarcomas including metastatic disease
Ideal for categorizing pediatric tumors of all types
Improved accuracy and reliability of tumor classification using Bethesda classifier
Reports MGMT promoter methylation status and chromosome copy number, including 1p/19q co-deletion
Identifies key oncogene amplifications and key tumor suppressor deletions
Identifies new epigenetic subgroups of tumors
Protean’s epigenetic profiling report provides the information you need in a clear and easy to understand format.
MGMT promoter methylation status
Chromosome copy number (including 1p/19q co-deletion)
Key oncogene amplifications
Key tumor suppressor deletions
Epigenetic subgroups of tumors
Ordering Process:
Complete the CNS test requisition form
Send the completed test requisition form via fax or Protean’s secure electronic portal
Ship tissue or slides with pathology report to Protean’s laboratory
Receive results within 5-10 business days
Sample Requirements:
FFPE tissue block or 20 unstained slides.
Overnight shipping required for tissue blocks.
Regular shipping for slides.
Details for slides: 5 micron thick sections, unstained & unbaked, 25 mm² (if less than this size, please provide additional slides), H&E optional
The Protean MAPS® System
Methylation Profiling is part of Protean’s full molecular analysis system for CNS tumors.
Protean MAPS® includes Methylation, pathology review, IHC, rapid IDH1/2 mutation testing, NGS profiling and complex fusion analysis
Order Epigenetic Profiling
Fill out your name and email address below and someone from Protean’s support team will be in touch shortly.
